These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8891083)

  • 1. Citalopram as an adjuvant in chronic schizophrenia: a double-blind placebo-controlled study.
    Salokangas RK; Saarijärvi S; Taiminen T; Kallioniemi H; Lehto H; Niemi H; Tuominen J; Ahola V; Syvälahti E
    Acta Psychiatr Scand; 1996 Sep; 94(3):175-80. PubMed ID: 8891083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of smoking on neuroleptics in schizophrenia.
    Salokangas RK; Saarijärvi S; Taiminen T; Lehto H; Niemi H; Ahola V; Syvälahti E
    Schizophr Res; 1997 Jan; 23(1):55-60. PubMed ID: 9050128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
    Barnes TR; Leeson VC; Paton C; Costelloe C; Simon J; Kiss N; Osborn D; Killaspy H; Craig TK; Lewis S; Keown P; Ismail S; Crawford M; Baldwin D; Lewis G; Geddes J; Kumar M; Pathak R; Taylor S
    Health Technol Assess; 2016 Apr; 20(29):1-46. PubMed ID: 27094189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
    Usall J; López-Carrilero R; Iniesta R; Roca M; Caballero M; Rodriguez-Jimenez R; Oliveira C; Bernardo M; Corripio I; Sindreu SD; González Piqueras JC; Felipe AE; Fernandez de Corres B; Ibáñez A; Huerta R;
    J Clin Psychiatry; 2014 Jun; 75(6):608-15. PubMed ID: 25004184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial.
    Ding N; Li Z; Liu Z
    Neurosci Lett; 2018 Aug; 681():68-72. PubMed ID: 29852208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: a randomized double-blind placebo-controlled trial.
    Iancu I; Tschernihovsky E; Bodner E; Piconne AS; Lowengrub K
    Psychiatry Res; 2010 Aug; 179(1):19-23. PubMed ID: 20472299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effects of antidepressants on negative symptoms in schizophrenia.
    Hinkelmann K; Yassouridis A; Kellner M; Jahn H; Wiedemann K; Raedler TJ
    J Clin Psychopharmacol; 2013 Oct; 33(5):686-90. PubMed ID: 23857309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial.
    Zisook S; Kasckow JW; Lanouette NM; Golshan S; Fellows I; Vahia I; Mohamed S; Rao S
    J Clin Psychiatry; 2010 Jul; 71(7):915-22. PubMed ID: 20361918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram as an adjuvant in schizophrenia: further evidence for a serotonergic dimension in schizophrenia.
    Taiminen TJ; Syvälahti E; Saarijärvi S; Niemi H; Lehto H; Ahola V; Salokangas RK
    Int Clin Psychopharmacol; 1997 Jan; 12(1):31-5. PubMed ID: 9179631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP; Overø K
    J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ; Gergel I; Bose A
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
    Wade AG; Crawford GM; Nemeroff CB; Schatzberg AF; Schlaepfer T; McConnachie A; Haazen L; Buntinx E
    Psychol Med; 2011 Oct; 41(10):2089-97. PubMed ID: 21349239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
    Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
    J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
    Pallanti S; Quercioli L; Koran LM
    J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-On Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Kardashev A; Ratner Y; Ritsner MS
    Clin Schizophr Relat Psychoses; 2018; 12(1):31-41. PubMed ID: 26218236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia.
    Friedman JI; Ocampo R; Elbaz Z; Parrella M; White L; Bowler S; Davis KL; Harvey PD
    J Clin Psychopharmacol; 2005 Jun; 25(3):237-42. PubMed ID: 15876902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.